Amarin | AMRN - Cost Of Sales

Amarin reported $23.94M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Alnylam Pharmaceuticals ALNY:US USD 51.27M 10.15M
Amarin AMRN:US USD 23.94M 11.87M
AstraZeneca AZN:LN USD 2.51B 393M
Biocryst Pharmaceuticals BCRX:US USD 2.5M 1.12M
Esperion Therapeutics ESPR:US USD 4.16M 2.35M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Halozyme Therapeutics HALO:US USD 42.12M 5.2M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Intercept Pharmaceuticals ICPT:US USD 28K 396K
IONIS PHARMACEUT IONS:US USD 3.69M 2.17M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Nektar Therapeutics NKTR:US USD 6.23M 1.26M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Novartis NOVN:VX USD 3.84B 180M
Teva Pharmaceutical Industries TEVA:US USD 1.78B 101M